Runben Biotechnology Co., Ltd. (SHA:603193)
23.85
-0.35 (-1.45%)
At close: Feb 6, 2026
-7.56% (1Y)
| Market Cap | 9.65B -2.8% |
| Revenue (ttm) | 1.52B +21.8% |
| Net Income | 305.33M -0.3% |
| EPS | 0.76 -0.1% |
| Shares Out | 404.59M |
| PE Ratio | 31.42 |
| Forward PE | 28.62 |
| Dividend | 0.46 (1.93%) |
| Ex-Dividend Date | Sep 18, 2025 |
| Volume | 2,191,400 |
| Average Volume | 3,041,923 |
| Open | 24.11 |
| Previous Close | 24.20 |
| Day's Range | 23.83 - 24.19 |
| 52-Week Range | 23.40 - 44.00 |
| Beta | 0.05 |
| RSI | 41.93 |
| Earnings Date | Apr 23, 2026 |